Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Happy Hunting: Tyco Nellcor, Masimo Find Dual-Source Contracts Abet Sales

This article was originally published in The Gray Sheet

Executive Summary

Tyco Nellcor looks to sustain 5% sales growth for its pulse oximetry products in the face of increasing price pressure and competition eroding the firm's more than 80% U.S. market share
Advertisement

Related Content

Nellcor Seeks Reversal Of $134 Mil. Pulse Oximeter Infringement Jury Award
Nellcor Seeks Reversal Of $134 Mil. Pulse Oximeter Infringement Jury Award
IPO Flurry In 2004? Aspirants Stress Profitability, Economic Upturn As Key
IPO Flurry In 2004? Aspirants Stress Profitability, Economic Upturn As Key
IPO Flurry In 2004? Aspirants Stress Profitability, Economic Upturn As Key
GEMS Commitment Will Facilitate EU Clearance Of Spacelabs Purchase – OSI
GPO Sole-Source Contract Reassessments Sought In Wake Of Senate Hearing
GPO Sole-Source Contract Reassessments Sought In Wake Of Senate Hearing
Mallinckrodt Responds To Masimo Infringement Suit With Counterclaim
Advertisement
UsernamePublicRestriction

Register

MT019710

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel